North America Immunodiagnostic Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product [Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays (Vitamin D Assay, HIV Detection, HIV Ag/Ab Combo Assay, and Others), Radioimmunoassays, and Others], Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)

No. of Pages: 198    |    Report Code: BMIRE00026558    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Immunodiagnostic Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Immunodiagnostic Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Immunodiagnostic Market – Key Market Dynamics

5.1 Growth Drivers
5.2 Market Opportunities
5.3 Future Trends
5.4 Impact of Drivers and Restraints

6. North America Immunodiagnostic Market Regional Analysis

6.1 North America Immunodiagnostic Market Overview
6.2 North America Immunodiagnostic Market Revenue 2019-2028 (US$ Million)
6.3 North America Immunodiagnostic Market Forecast Analysis

7. North America Immunodiagnostic Market Analysis – by Product

7.1 Enzyme-Linked Immunosorbent Assays
  • 7.1.1 Overview
  • 7.1.2 Enzyme-Linked Immunosorbent Assays: North America Immunodiagnostic Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Chemiluminescence Immunoassays
  • 7.2.1 Overview
  • 7.2.2 Chemiluminescence Immunoassays: North America Immunodiagnostic Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Radioimmunoassays
  • 7.3.1 Overview
  • 7.3.2 Radioimmunoassays: North America Immunodiagnostic Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Immunodiagnostic Market Analysis – by Clinical Indication

8.1 Infectious Diseases
  • 8.1.1 Overview
  • 8.1.2 Infectious Diseases: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Hepatitis+HIV
  • 8.2.1 Overview
  • 8.2.2 Hepatitis+HIV: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Gastrointestinal
  • 8.3.1 Overview
  • 8.3.2 Gastrointestinal: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Metabolics
  • 8.4.1 Overview
  • 8.4.2 Metabolics: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Endocrinology
  • 8.5.1 Overview
  • 8.5.2 Endocrinology: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Immunodiagnostic Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Endocrinology: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Endocrinology: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Diagnostic Laboratories
  • 9.3.1 Overview
  • 9.3.2 Endocrinology: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Academic & Research Institutes
  • 9.4.1 Overview
  • 9.4.2 Endocrinology: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Immunodiagnostic Market – North America Analysis

10.1 North America
  • 10.1.1 North America Immunodiagnostic Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Immunodiagnostic Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Immunodiagnostic Market Breakdown, by Product
    • 10.1.1.1.2 US: North America Immunodiagnostic Market Breakdown, by Clinical Indication
    • 10.1.1.1.3 US: North America Immunodiagnostic Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Immunodiagnostic Market Breakdown, by Product
    • 10.1.1.2.2 Canada: North America Immunodiagnostic Market Breakdown, by Clinical Indication
    • 10.1.1.2.3 Canada: North America Immunodiagnostic Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Immunodiagnostic Market Breakdown, by Product
    • 10.1.1.3.2 Mexico : North America Immunodiagnostic Market Breakdown, by Clinical Indication
    • 10.1.1.3.3 Mexico : North America Immunodiagnostic Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Immunodiagnostic Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 DiaSorin S.p.A.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Danaher Corp
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Siemens Healthineers AG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 PerkinElmer Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 bioMerieux SA
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. Abbott Laboratories          
  2. F. Hoffmann-La Roche Ltd               
  3. DiaSorin S.p.A.     
  4. Danaher Corp       
  5. Thermo Fisher Scientific Inc            
  6. Siemens Healthineers AG               
  7. PerkinElmer Inc.                  
  8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.   
  9. bioMerieux SA
north-america-immunodiagnostic-market